Xometry (XMTR) Competitors

Medpace has a net margin of 17.19% compared to Xometry's net margin of -7.01%. Medpace's return on equity of 120.89% beat Xometry's return on equity.

97.3% of Xometry shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 9.1% of Xometry shares are held by insiders. Comparatively, 20.5% of Medpace shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Medpace's average media sentiment score of 0.61 beat Xometry's score of 0.00 indicating that Medpace is being referred to more favorably in the news media.

Xometry has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, Medpace has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market.

Xometry currently has a consensus target price of $76.00, indicating a potential downside of 17.23%. Medpace has a consensus target price of $467.08, indicating a potential downside of 16.23%. Given Medpace's higher possible upside, analysts plainly believe Medpace is more favorable than Xometry.

Medpace has higher revenue and earnings than Xometry. Xometry is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Rentokil Initial has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Xometry has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

Rentokil Initial has higher revenue and earnings than Xometry.

9.9% of Rentokil Initial shares are owned by institutional investors. Comparatively, 97.3% of Xometry shares are owned by institutional investors. 9.1% of Xometry shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Rentokil Initial had 1 more articles in the media than Xometry. MarketBeat recorded 1 mentions for Rentokil Initial and 0 mentions for Xometry. Rentokil Initial's average media sentiment score of 1.05 beat Xometry's score of 0.00 indicating that Rentokil Initial is being referred to more favorably in the media.

Rentokil Initial presently has a consensus price target of $34.50, indicating a potential upside of 14.94%. Xometry has a consensus price target of $76.00, indicating a potential downside of 17.23%. Given Rentokil Initial's stronger consensus rating and higher possible upside, equities research analysts clearly believe Rentokil Initial is more favorable than Xometry.

Rentokil Initial has a net margin of 0.00% compared to Xometry's net margin of -7.01%. Rentokil Initial's return on equity of 0.00% beat Xometry's return on equity.

Grab has higher revenue and earnings than Xometry. Xometry is trading at a lower price-to-earnings ratio than Grab, indicating that it is currently the more affordable of the two stocks.

Xometry presently has a consensus target price of $76.00, indicating a potential downside of 17.23%. Grab has a consensus target price of $6.23, indicating a potential upside of 59.69%. Given Grab's stronger consensus rating and higher possible upside, analysts plainly believe Grab is more favorable than Xometry.

Grab has a net margin of 10.67% compared to Xometry's net margin of -7.01%. Grab's return on equity of 5.79% beat Xometry's return on equity.

In the previous week, Grab had 7 more articles in the media than Xometry. MarketBeat recorded 7 mentions for Grab and 0 mentions for Xometry. Grab's average media sentiment score of 0.40 beat Xometry's score of 0.00 indicating that Grab is being referred to more favorably in the news media.

97.3% of Xometry shares are owned by institutional investors. Comparatively, 55.5% of Grab shares are owned by institutional investors. 9.1% of Xometry shares are owned by insiders. Comparatively, 3.6% of Grab shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Xometry has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, Grab has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

In the previous week, Toast had 3 more articles in the media than Xometry. MarketBeat recorded 3 mentions for Toast and 0 mentions for Xometry. Toast's average media sentiment score of 0.85 beat Xometry's score of 0.00 indicating that Toast is being referred to more favorably in the media.

Toast has a beta of 1.74, meaning that its share price is 74% more volatile than the broader market. Comparatively, Xometry has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

82.9% of Toast shares are owned by institutional investors. Comparatively, 97.3% of Xometry shares are owned by institutional investors. 10.0% of Toast shares are owned by company insiders. Comparatively, 9.1% of Xometry shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Toast has higher revenue and earnings than Xometry. Xometry is trading at a lower price-to-earnings ratio than Toast, indicating that it is currently the more affordable of the two stocks.

Toast has a net margin of 6.39% compared to Xometry's net margin of -7.01%. Toast's return on equity of 20.86% beat Xometry's return on equity.

Toast currently has a consensus price target of $37.62, suggesting a potential upside of 30.68%. Xometry has a consensus price target of $76.00, suggesting a potential downside of 17.23%. Given Toast's stronger consensus rating and higher possible upside, equities research analysts clearly believe Toast is more favorable than Xometry.